The Discounted Cash Flow (DCF) valuation of Enzon Pharmaceuticals Inc (ENZN) is 0.26 USD. With the latest stock price at 0.09 USD, the upside of Enzon Pharmaceuticals Inc based on DCF is 178.9%.
Based on the latest price of 0.09 USD and our DCF valuation, Enzon Pharmaceuticals Inc (ENZN) is a buy. buying ENZN stocks now will result in a potential gain of 178.9%.
| Range | Selected | |
| WACC / Discount Rate | 6.0% - 6.9% | 6.5% |
| Long-term Growth Rate | 0.0% - 1.0% | 0.5% |
| Fair Price | 0.20 - 0.30 | 0.26 |
| Upside | 113.2% - 226.7% | 178.9% |